Trial · NCT00913770
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
NCT00913770, Not applicable, Completed, Yale University; results first posted 2015-05-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department. Trials, record NCT00913770. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00913770
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
- NCT number
- NCT00913770
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 329 participants, actual
- Lead sponsor
- Yale University
- Conditions
- Opiate Addiction
- Interventions
- Brief Negotiation Interview (BNI), Buprenorphine Initiation
- First posted
- 2009-06-04
- Last updated
- 2020-03-24
- Results first posted
- 2015-05-28
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Self-reported Engagement in Formal Substance Abuse Treatment at 30 Days (Verified by Contact With the Treatment Program) | 30 days post randomization | Defined as enrollment and receiving formal addiction treatment on the 30th day following randomization. This is assessed by direct contact with facility, clinician, or both. |
| Secondary | Days of Self-reported Illicit Opioid Use in the Past 7 Days | 30 days post randomization |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Self-reported Engagement in Formal Substance Abuse Treatment at 30 Days (Verified by Contact With the Treatment Program) | 30 days post randomization | All subjects who were randomized to receive treatment were included in the primary analysis. 2 subjects were lost to follow up in the standard of care arm which is why 102 are included in the analysis instead of 104 | Mean Number of Outpatient Visits | MEAN |
| SECONDARY | Days of Self-reported Illicit Opioid Use in the Past 7 Days | 30 days post randomization | All subjects who were randomized to receive treatment were included in the primary analysis. 2 subjects were lost to follow up in the standard of care arm which is why 102 are included in the analysis instead of 104 | Mean Number of Days | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Self-reported Engagement in Formal Substance Abuse Treatment at 30 Days (Verified by Contact With the Treatment Program) | Standard Care | 4.99 | 95% Confidence Interval 3.1 to 6.8 | Mean Number of Outpatient Visits | |
| Self-reported Engagement in Formal Substance Abuse Treatment at 30 Days (Verified by Contact With the Treatment Program) | SBIRT | 5.67 | 95% Confidence Interval 4.0 to 7.4 | Mean Number of Outpatient Visits | |
| Self-reported Engagement in Formal Substance Abuse Treatment at 30 Days (Verified by Contact With the Treatment Program) | SBI+Bup | 3.71 | 95% Confidence Interval 2.1 to 5.3 | Mean Number of Outpatient Visits | |
| Days of Self-reported Illicit Opioid Use in the Past 7 Days | Standard Care | 2.3 | 95% Confidence Interval 1.7 to 3.0 | Mean Number of Days | |
| Days of Self-reported Illicit Opioid Use in the Past 7 Days | SBIRT | 2.4 | 95% Confidence Interval 1.8 to 3.0 | Mean Number of Days | |
| Days of Self-reported Illicit Opioid Use in the Past 7 Days | SBI+Bup | 0.9 | 95% Confidence Interval 0.5 to 1.3 | Mean Number of Days |
Source ClinicalTrials.gov
Participant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard Care | 104 | |
| Overall Study | STARTED | SBIRT | 111 | |
| Overall Study | STARTED | SBI+Bup | 114 | |
| Overall Study | COMPLETED | Standard Care | 69 | |
| Overall Study | COMPLETED | SBIRT | 82 | |
| Overall Study | COMPLETED | SBI+Bup | 93 | |
| Overall Study | NOT COMPLETED | Standard Care | 35 | |
| Overall Study | NOT COMPLETED | SBIRT | 29 | |
| Overall Study | NOT COMPLETED | SBI+Bup | 21 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard Care | ||
| Total, all-cause mortality | SBIRT | ||
| Total, all-cause mortality | SBI+Bup | ||
| Total, other adverse events | Standard Care | 0 | 104 |
| Total, other adverse events | SBIRT | 0 | 111 |
| Total, other adverse events | SBI+Bup | 0 | 114 |
| Total, serious adverse events | Standard Care | 0 | 104 |
| Total, serious adverse events | SBIRT | 0 | 111 |
| Total, serious adverse events | SBI+Bup | 0 | 114 |
Source ClinicalTrials.gov
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01DA025991 | Models of SBIRT for Opioid Dependent Patients in the Emergency Department | D'ONOFRIO, GAIL; FIELLIN, DAVID | YALE UNIVERSITY | NATIONAL INSTITUTE ON DRUG ABUSE | 2008 to 2012 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00913770
GET https://conductscience.org/api/trials/v1/NCT00913770/registered